QT
LXRX icon

Quantbot Technologies’s Lexicon Pharmaceuticals LXRX Stock Holding History

Quantbot Technologies’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,625
Closed -$7K – 1944
2022
Q1 		$7K Hold
3,625
– – ﹤0.01% 1496
2021
Q4 		$14K Hold
3,625
– – ﹤0.01% 1271
2021
Q3 		$17K Hold
3,625
– – ﹤0.01% 1296
2021
Q2 		$16K Sell
3,625
-24,317
-87% -$117K ﹤0.01% 1249
2021
Q1 		$164K Buy
+27,942
New +$193K 0.02% 763
2020
Q1 		– Sell
-34,976
Closed -$145K – 1170
2019
Q4 		$145K Buy
+34,976
New +$135K 0.01% 734
2018
Q4 		– Sell
-8,610
Closed -$91K – 1238
2018
Q3 		$91K Buy
+8,610
New +$98.7K 0.01% 902
2017
Q3 		– Sell
-4,403
Closed -$72K – 1331
2017
Q2 		$72K Buy
+4,403
New +$68.2K 0.01% 859
2017
Q1 		– Sell
-14,988
Closed -$207K – 1300
2016
Q4 		$207K Buy
+14,988
New +$240K 0.02% 547
2016
Q3 		– Sell
-13,999
Closed -$200K – 1210
2016
Q2 		$200K Buy
13,999
+1,529
+12% +$20.7K 0.02% 570
2016
Q1 		$149K Buy
12,470
+10,191
+447% +$107K 0.02% 623
2015
Q4 		$30K Buy
+2,279
New +$28K 0.01% 886

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantbot Technologies's LXRX Position: Q2 2022 in Review

Quantbot Technologies sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2022, closing a stake of 3,625 shares — an estimated $7K sold.

Quantbot Technologies first reported a position in LXRX in Q4 2015 and held it in 12 quarters. The position peaked at $207K in Q4 2016. 86 funds tracked by Wall St. Rank hold LXRX as of Q2 2022.

  • Quantbot Technologies reported no remaining Lexicon Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Quantbot Technologies sold 3,625 Lexicon Pharmaceuticals shares in Q2 2022, an estimated $7K.
  • Quantbot Technologies first reported a position in Lexicon Pharmaceuticals in Q4 2015 and held it in 12 quarters.
  • Quantbot Technologies's Lexicon Pharmaceuticals position peaked at $207K in Q4 2016.
  • 86 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2022.

Based on Quantbot Technologies's 13F filing for Q2 2022, filed 9 Aug 2022.